WuXi Biologics
Offering End-to-End Solutions
Most of the linker-payloads used for ADCs are highly potent and cytotoxic compounds. Deprotection and reduction of compounds by hydrogenation is one of the most common reactions in linker-payload synthesis. However, hydrogenation is one of the challenging processes to handle in high potency (HP) production areas due to safety requirements. Additionally, batch mode production limit’s reaction scale and can result in incomplete conversion due to the difficulty of applying high pressure. This poster reviews how a simplified process using a small-scale flow mode operation can successfully mitigate safety risks and offer high conversion with great ease of operation.
This scientific poster was originally presented during the 2024 World ADC Conference in London
Discuss This Poster
To discuss the data in this poster, please complete the form on the following page to connect with our experts.
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?